Balbay M.D.Yildiz M.Salvarci A.Özsan Ö.Özbek E.2024-08-042024-08-0419980301-1623https://doi.org/10.1007/BF02550283https://hdl.handle.net/11616/90574To evaluate the efficacy of oral sertralin in the treatment of premature ejaculation, out of 22 patients with premature ejaculation 16 received oral sertralin, 50 mg a day for at least 2 weeks. Four patients were lost to follow-up. Two patients interrupted treatment due to side effects of sertralin. Out of 16 patients who completed at least a two-week period of treatment 14 (87.5%) responded clinically. Clinical response was achieved in the first week of treatment in 11 of 16 responders (68.75%). We conclude that low dose oral sertralin may be useful with a reasonable side effect rate in the treatment of patients suffering from premature ejaculation.eninfo:eu-repo/semantics/closedAccesssertralineadultanorgasmiaappetite disorderarticleclinical articledose responsedrug efficacyhumanmalemale sexual dysfunctionnauseaoral drug administrationpenis erectionpremature ejaculationsweatingvertigoyawningArticle3018183956911710.1007/BF025502832-s2.0-0031695161Q2